Clinical Trial Update: A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy trial comparing aliskiren (150 mg and 300 mg) with ramipril (5 mg and 10 mg) in elderly patients with hypertension; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• Ramipril (ramipril)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-03-25